-
Polygodial and the TRPA1 Translation Gap
2026-08-15
Polygodial offers translational researchers a chemically defined way to interrogate TRPA1-dependent calcium signaling, from channel activation to epithelial inflammatory outputs. This thought-leadership guide connects TRPA1 ion channel modulation with assay strategy, experimental controls, and the limits of translating pathway activation into airway biology.
-
1-myristoylglycerophosphocholine in Lipid Signaling
2026-08-15
Explore how 1-myristoylglycerophosphocholine and 14:0 Lyso-PC can sharpen lipid signaling pathway analysis, with a species-aware framework informed by pulmonary fibrosis research and practical assay design.
-
Azithromycin Workflows for Macrolide Research
2026-08-14
Build matrix-aware MIC, time-kill, resistance, and analytical workflows around Azithromycin rather than relying on a single endpoint. The approach connects bacterial protein synthesis studies with carefully bounded trypanosomosis research while emphasizing solvent control, drug stability, and translational limitations.
-
Hesperadin: A Precision Lens on Mitotic Checkpoints
2026-08-14
Hesperadin is an Aurora B kinase inhibitor that reveals how kinase-dependent chromosome control intersects with mitotic checkpoint timing. This article connects its biochemical and cellular phenotypes with the Plk1–p31comet mechanism to improve assay design and interpretation.
-
β-Elemene Assay Design: From Signal to Mechanism
2026-08-13
β-Elemene is a context-dependent research tool for connecting lipid accumulation, insulin resistance, and AMPK signaling. This guide translates recent 3T3-L1 evidence into better assay design while defining the boundaries of β-elemene neuroprotection and apoptosis studies.
-
TRPV1 and TRPA1 Drive Nasal TSLP Production
2026-08-13
The reference study shows that TRPV1 and TRPA1 are present in nasal epithelial cells and connect channel activation to TSLP production through calcium-dependent NFAT signaling. Its combined imaging, pharmacological, gene-silencing, and calcium-chelation approach helps distinguish TSLP regulation from broader cytokine responses and provides a mechanistic framework for upper-airway inflammation research.
-
Cisapride (R 51619) in Cardiac Screening
2026-08-12
Cisapride (R 51619) combines 5-HT4 receptor agonism with hERG channel inhibition, making it a useful challenge compound for linking serotonergic signaling to cardiac electrophysiology. This workflow shows how to deploy it in iPSC-derived cardiomyocyte assays, high-content imaging, and orthogonal arrhythmia studies while controlling vehicle, solubility, and assay-interpretation risks.
-
Tunable Human Intestinal Organoids: Study Insights
2026-08-12
A recent Nature Communications study establishes a human small intestinal organoid system that maintains proliferation while expanding epithelial cell diversity under a unified culture framework. Its central innovation is the use of coordinated pathway modulation to increase stem-cell competence and then reversibly or directionally tune lineage output without recreating artificial spatial signaling gradients.
-
Caspase-3/7 Inhibitor I in Apoptosis Workflows
2026-08-11
Caspase-3/7 Inhibitor I enables selective, reversible suppression of executioner caspases in cell-based apoptosis studies. This guide connects compound handling, caspase activity measurement, and Candida krusei infection models to practical controls, assay choices, and troubleshooting decisions.
-
CK2 and ERK8 Inhibitor B7464 Research Guide
2026-08-10
The 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid is a small molecule inhibitor for research on CK2- and ERK8-linked phosphorylation. B7464 supports biochemical assay development, but published evidence for SARS-CoV-2 nucleocapsid phase separation concerns GCG rather than this kinase inhibitor.
-
Optimized GBA1 mRNA for Gaucher Disease Therapy
2026-08-09
The reference study systematically optimized human GBA1 mRNA through untranslated-region design, codon selection, and poly(A)-tail engineering to increase functional glucocerebrosidase expression. Its cellular and mouse data show improved lysosomal delivery, restored activity in GBA1-deficient cells, and detectable enzyme activity in liver and spleen after lipid nanoparticle administration.
-
Marein Reverses ABCG2-Mediated Chemoresistance
2026-08-08
The reference study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug transporter. By increasing intracellular exposure to ABCG2 substrate drugs and restoring drug sensitivity in resistant cancer cells, the work provides a mechanistic basis for evaluating marein as a chemosensitizing compound.
-
Rotigotine Workflows for Parkinson’s Disease Models
2026-08-07
Rotigotine enables controlled dopamine-receptor activation, neuroprotection testing, and delivery comparisons in cell and animal models. This workflow-focused guide connects SH-SY5Y assays with haloperidol and nose-to-brain nanoparticle studies while emphasizing dosing, controls, and troubleshooting.
-
(5Z)-7-Oxozeaenol: Advanced TAK1 Inhibitor Workflows & Troub
2026-08-07
(5Z)-7-Oxozeaenol delivers exceptional selectivity and potency for dissecting TAK1-dependent inflammatory and metabolic signaling. This guide details protocol enhancements, troubleshooting strategies, and real-world applications, translating cutting-edge mechanistic insights into actionable workflows for researchers.
-
Vitamin D Receptor Drives Ferroptosis in Female Sod1 KO Sali
2026-08-06
This study uncovers a sex-specific mechanism linking vitamin D receptor (VDR) upregulation to ferroptosis-driven salivary hyposecretion in female Sod1 knockout mice. The findings highlight VDR as a modulator of ferroptosis via transferrin receptor expression, providing new research avenues for dry mouth and salivary gland dysfunction under oxidative stress.